FDA secures new pay deal for civil servants
This package includes:
- An addendum to the 2023/24 Pay Remit Guidance to enable employers to pay an additional fixed £1,500 non-consolidated payment to assist with the increased cost of living. This will be paid to all civil servants covered by the pay remit process, including those on the centralised fast stream and will be subject to pro-rata arrangements for part time staff.
- A commitment that the introduction of capability-based pay for the SCS is a ministerial priority and that the Cabinet Office will undergo a period of work as a matter of priority. The minister has committed to intensive engagement with the FDA on this issue and agreed meet with us as part of his personal commitment to its implementation.
- A commitment to make no changes to the Civil Service Compensation Scheme before 2025. Alongside a commitment to avoid compulsory redundancies across the civil service.
You can read the full details of the proposed package on the gov.uk website.
FDA General Secretary Dave Penman has welcomed this new pay deal: “The threat of industrial action must always be a last resort and the FDA’s decision to ballot for national industrial action over pay for the first time in 40 years was not taken lightly. It was intended to send a clear message to the government that enough was enough as they had failed to demonstrate that they valued the civil service equally with the rest of the public sector.
Related News
-
Never again
Following the unacceptable issues arising from the civil service pension scheme transfer to Capita, Adrian Prandle outlines the FDA’s ongoing work to ensure members get the support they need as quickly as possible.
-
Integrated Public Sector Pay and Workforce Policy ‘quietly hard-wires job losses into pay’ creating ‘permanent squeeze’ on staff, says FDA
FDA National Officer for Scotland Allan Sampson has responded to the Integrated Public Sector Pay and Workforce Policy, announced in the 2026 Scottish Budget.
-
FDA calls for rapid improvement following “unacceptable” pension administrator performance
Following the transfer of administration of the civil service pension scheme from MyCSP to Capita at the end of last year, the FDA continue to hear from hundreds of current and retired members who are continuing to be impacted by service levels.
